Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment of prostate cancer (ID 3588) and “upper respiratory tract” (ID 3589) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Soy isoflavones, oxidative damage, cholesterol, skin tonicity, hair growth, vasomotor symptoms, menopause, prostate cancer, cardiovascular health, upper respiratory tract, health claims
First published in the EFSA Journal:
28 luglio 2011
Adopted:
30 giugno 2011
Type:
Scientific Opinion
Read it on the Wiley Online Library: Abstract
No abstract available
© European Food Safety Authority, 2011
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
Contact:
nda [at] efsa.europa.eu
doi:
10.2903/j.efsa.2011.2264
EFSA Journal 2011;9(7):2264
Question Number:
On request from:
European Commission